COLANTONIO, Ida
 Distribuzione geografica
Continente #
NA - Nord America 205
EU - Europa 79
AS - Asia 51
SA - Sud America 4
OC - Oceania 1
Totale 340
Nazione #
US - Stati Uniti d'America 203
IT - Italia 37
CN - Cina 18
SG - Singapore 17
IE - Irlanda 12
SE - Svezia 10
GB - Regno Unito 5
DE - Germania 4
FR - Francia 4
VN - Vietnam 4
BR - Brasile 3
KR - Corea 3
CA - Canada 2
ID - Indonesia 2
IN - India 2
JP - Giappone 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
BE - Belgio 1
FI - Finlandia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
NL - Olanda 1
NO - Norvegia 1
PK - Pakistan 1
UA - Ucraina 1
Totale 340
Città #
Chandler 27
Santa Clara 23
Fairfield 21
Singapore 14
Dublin 12
Woodbridge 9
Seattle 8
Wilmington 8
Nyköping 7
Torino 7
Beijing 6
Houston 6
Ashburn 5
Cambridge 4
Columbus 4
Hangzhou 4
Medford 4
Princeton 4
Guangzhou 3
Turin 3
Ann Arbor 2
Boston 2
Dearborn 2
Dong Ket 2
Jakarta 2
Mutterstadt 2
Rome 2
Seoul 2
Vicopisano 2
Barzanò 1
Brussels 1
Budapest 1
Changsha 1
Chatsworth 1
Chicago 1
Duncan 1
Fano 1
Fremont 1
Hangyang 1
Hebei 1
Helsinki 1
Hopkins 1
Jaboatao dos Guararapes 1
Jacksonville 1
Kilburn 1
Kunming 1
London 1
Marseille 1
Maynard 1
Milan 1
Naples 1
Ottawa 1
Parma 1
Perth 1
Portland 1
Quartu Sant'elena 1
Redwood City 1
Riverton 1
San Diego 1
San Mateo 1
Shenyang 1
Silver Spring 1
São Paulo 1
Taranto 1
Tokyo 1
Upper Marlboro 1
Venezia 1
Yerevan 1
Ypsilanti 1
Totale 237
Nome #
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) 126
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial 84
Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice 81
International Tailored Chemotherapy Adjuvant (ITACA) Trial, a Phase III Multicenter Randomized Trial Comparing Adjuvant Pharmacogenomic-Driven Chemotherapy versus Standard Adjuvant Chemotherapy in completely Resected Stage II-IIIA Non-Small Cell Lung Cancer 61
Totale 352
Categoria #
all - tutte 1.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 3 6 2 1 1 3 0
2020/202181 0 2 38 1 4 2 0 10 5 4 5 10
2021/202274 6 2 1 5 7 5 7 1 1 6 23 10
2022/202384 15 12 1 7 6 15 3 3 17 1 2 2
2023/202432 4 11 3 1 2 1 2 0 0 3 1 4
2024/202558 0 14 4 7 24 9 0 0 0 0 0 0
Totale 352